Obalon Therapeutics Inc (OBLN) Forecast, Price Target & Analyst Ratings
NASDAQ:OBLN
3.05
-0.19 (-5.86%)
At close: Jun 15, 2021
3.12
+0.07 (+2.3%)
After Hours: 6/15/2021, 8:00:01 PM
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for Obalon Therapeutics Inc (OBLN).
Forecast Snapshot
Consensus Price Target
$18.82
+ 517.02% Upside
Next Earnings Forecast
Release DateMar 11, 2022
PeriodQ2 / 2021
EPS Estimate-$0.47
Revenue Estimate3.857M
ChartMill Buy Consensus
0.00%
Weighted Analyst Rating Score
Price Target Details & History
Consensus Price Target and Range
Mean target
$18.82
Upside
+ 517.02%
From current price of $3.05 to mean target of $18.82, Based on 0 analyst forecasts
Low
$18.63
Median
$18.82
High
$19.37
Price Target Revisions
1 Month
N/A
3 Months
N/A
Price Target Summary
0 analysts have analysed OBLN and the average price target is 18.82 null. This implies a price increase of 517.02% is expected in the next year compared to the current price of 3.05.
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
0.00%
OBLN is currently not analyzed by any analysts.
Recent Upgrades & Downgrades
Next Earnings Forecast Details
Next Earnings Details
Release DateMar 11, 2022
PeriodQ2 / 2021
EPS Estimate-$0.47
Revenue Estimate3.857M
Revenue Q2QN/A
EPS Q2Q71.04%
Number of Analysts3
Next Earnings Revisions
Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
N/A
EPS (3 Months)
N/A
Next Earnings Summary
OBLN is expected to report earnings on 3/11/2022. The consensus EPS estimate for the next earnings is -0.47 null and the consensus revenue estimate is 3.86M null.
Full Analyst Estimates
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | N/A | N/A 203.07% | N/A -9.11% | N/A -67.76% | N/A -49.32% | N/A 953.33% | N/A 32.91% | N/A 484.36% | N/A 493.12% | |
| EBITDA YoY % growth | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | N/A | -62.40 25.58% | -58.50 6.25% | -22.05 62.31% | -4.77 78.37% | N/A 43.12% | N/A 44.74% | N/A 43.74% | N/A 42.61% |
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| Q2 / 21 | Q3 / 21 | Q4 / 21 | Q1 / 22 | Q2 / 22 | Q3 / 22 | Q4 / 22 | |
|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.47 71.04% | -0.46 23.50% | -0.46 10.00% | -0.45 -2.00% | -0.43 8.70% | -0.35 24.44% | -0.28 40.00% |
| Revenue Q2Q % growth | 3.857M | 4.365M | 4.568M | 4.568M | 4.771M 23.68% | 5.684M 30.23% | 6.394M 40.00% |
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
22.16%
EPS Next 5 Year
17.38%
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
334.11%
Revenue Next 5 Year
369.34%
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
Obalon Therapeutics Inc / OBLN Forecast FAQ
What is the price target for OBLN stock?
0 analysts have analysed OBLN and the average price target is 18.82 null. This implies a price increase of 517.02% is expected in the next year compared to the current price of 3.05.
When does Obalon Therapeutics Inc (OBLN) report earnings?
Obalon Therapeutics Inc (OBLN) will report earnings on 2022-03-11, after the market close.
Can you provide the consensus estimates for Obalon Therapeutics Inc next earnings?
The consensus EPS estimate for the next earnings of Obalon Therapeutics Inc (OBLN) is -0.47 null and the consensus revenue estimate is 3.86M null.